Legal & General Group’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-7,073
| Closed | -$4.6K | – | 3535 |
|
2025
Q1 | $4.6K | Hold |
7,073
| – | – | ﹤0.01% | 3288 |
|
2024
Q4 | $13K | Hold |
7,073
| – | – | ﹤0.01% | 3186 |
|
2024
Q3 | $24.5K | Hold |
7,073
| – | – | ﹤0.01% | 2968 |
|
2024
Q2 | $20.7K | Buy |
7,073
+2,113
| +43% | +$6.19K | ﹤0.01% | 3002 |
|
2024
Q1 | $28K | Hold |
4,960
| – | – | ﹤0.01% | 2866 |
|
2023
Q4 | $21.3K | Hold |
4,960
| – | – | ﹤0.01% | 3007 |
|
2023
Q3 | $17.2K | Sell |
4,960
-825
| -14% | -$2.86K | ﹤0.01% | 3096 |
|
2023
Q2 | $26.9K | Buy |
5,785
+639
| +12% | +$2.97K | ﹤0.01% | 2984 |
|
2023
Q1 | $23.8K | Hold |
5,146
| – | – | ﹤0.01% | 3018 |
|
2022
Q4 | $41.6K | Buy |
5,146
+551
| +12% | +$4.45K | ﹤0.01% | 2976 |
|
2022
Q3 | $26K | Buy |
4,595
+883
| +24% | +$5K | ﹤0.01% | 3139 |
|
2022
Q2 | $19K | Sell |
3,712
-7,558
| -67% | -$38.7K | ﹤0.01% | 3260 |
|
2022
Q1 | $92K | Hold |
11,270
| – | – | ﹤0.01% | 2889 |
|
2021
Q4 | $167K | Hold |
11,270
| – | – | ﹤0.01% | 2783 |
|
2021
Q3 | $213K | Buy |
11,270
+6,349
| +129% | +$120K | ﹤0.01% | 2673 |
|
2021
Q2 | $92K | Buy |
4,921
+1,511
| +44% | +$28.2K | ﹤0.01% | 2771 |
|
2021
Q1 | $78K | Buy |
3,410
+270
| +9% | +$6.18K | ﹤0.01% | 2688 |
|
2020
Q4 | $68K | Buy |
3,140
+203
| +7% | +$4.4K | ﹤0.01% | 2711 |
|
2020
Q3 | $30K | Buy |
2,937
+283
| +11% | +$2.89K | ﹤0.01% | 2852 |
|
2020
Q2 | $21K | Buy |
2,654
+1,257
| +90% | +$9.95K | ﹤0.01% | 3055 |
|
2020
Q1 | $14K | Sell |
1,397
-502
| -26% | -$5.03K | ﹤0.01% | 3055 |
|
2019
Q4 | $21K | Buy |
1,899
+80
| +4% | +$885 | ﹤0.01% | 3171 |
|
2019
Q3 | $17K | Hold |
1,819
| – | – | ﹤0.01% | 3186 |
|
2019
Q2 | $21K | Buy |
1,819
+832
| +84% | +$9.61K | ﹤0.01% | 3179 |
|
2019
Q1 | $11K | Hold |
987
| – | – | ﹤0.01% | 3238 |
|
2018
Q4 | $9K | Buy |
+987
| New | +$9K | ﹤0.01% | 3280 |
|